Arbutus Wins Patent-Claims Ruling in Moderna Covid Vaccine Case - Bloomberg Law News

Retrieved on: 2024-04-03 19:09:38

Tags for this article:

RNA

Arbutus Biopharma

Moderna

Messenger RNA

Vaccine

Arbutus Biopharma Corp

Click the tags to see associated articles and topics

Arbutus Wins Patent-Claims Ruling in Moderna Covid Vaccine Case - Bloomberg Law News. View article details on HISWAI: https://news.bloomberglaw.com/health-law-and-business/arbutus-wins-patent-claims-ruling-in-moderna-covid-vaccine-case

Summary

Arbutus Biopharma Corp., in a patent dispute with Moderna, gained favor in a court case regarding definitions of claims for lipid nanoparticle delivery technology used in Moderna's COVID-19 mRNA vaccine.

Article found on: news.bloomberglaw.com

View Original Article